Cargando…
Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease
AIMS AND OBJECTIVES: The aim of this study is to find easier way of home care while obviating the colostomy before single stage pull through operation. MATERIALS AND METHODS: From August 2005 to December 2006, eight cases of neonatal Hirschsprung disease were treated. Mean age 4.5 (2-6) day/old with...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788448/ https://www.ncbi.nlm.nih.gov/pubmed/20011471 http://dx.doi.org/10.4103/0971-9261.43025 |
_version_ | 1782174978014183424 |
---|---|
author | Hosseini, S. M. V. Foroutan, H. R. Zeraatian, S. Sabet, B. |
author_facet | Hosseini, S. M. V. Foroutan, H. R. Zeraatian, S. Sabet, B. |
author_sort | Hosseini, S. M. V. |
collection | PubMed |
description | AIMS AND OBJECTIVES: The aim of this study is to find easier way of home care while obviating the colostomy before single stage pull through operation. MATERIALS AND METHODS: From August 2005 to December 2006, eight cases of neonatal Hirschsprung disease were treated. Mean age 4.5 (2-6) day/old with absent anorectal inhibitory reflex, rectosigmiod disease in Barium enema, positive Acetylcholine esterase (Ache) staining, good response to rectal washout. They underwent botulinium toxin injection (5 unit /kg/quadrant) in four quadrant intrasphincteric. They were followed until pull through operation in 8-10 weeks post injection. RESULTS: Four of 8 (50%) cases only needed rectal washout for three to five days post injection until pull through operation, two had decrease in number of rectal washouts /day and the remaining two underwent colostomy five days post injection because of no response. CONCLUSION: Botulinium toxin injection can help in palliative care in patients with Hirschsprung disease who are waiting for colostomy or definitive pullthrough. It gives an option of eaiser home care for these patients. |
format | Text |
id | pubmed-2788448 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-27884482009-12-13 Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease Hosseini, S. M. V. Foroutan, H. R. Zeraatian, S. Sabet, B. J Indian Assoc Pediatr Surg Original Article AIMS AND OBJECTIVES: The aim of this study is to find easier way of home care while obviating the colostomy before single stage pull through operation. MATERIALS AND METHODS: From August 2005 to December 2006, eight cases of neonatal Hirschsprung disease were treated. Mean age 4.5 (2-6) day/old with absent anorectal inhibitory reflex, rectosigmiod disease in Barium enema, positive Acetylcholine esterase (Ache) staining, good response to rectal washout. They underwent botulinium toxin injection (5 unit /kg/quadrant) in four quadrant intrasphincteric. They were followed until pull through operation in 8-10 weeks post injection. RESULTS: Four of 8 (50%) cases only needed rectal washout for three to five days post injection until pull through operation, two had decrease in number of rectal washouts /day and the remaining two underwent colostomy five days post injection because of no response. CONCLUSION: Botulinium toxin injection can help in palliative care in patients with Hirschsprung disease who are waiting for colostomy or definitive pullthrough. It gives an option of eaiser home care for these patients. Medknow Publications 2008 /pmc/articles/PMC2788448/ /pubmed/20011471 http://dx.doi.org/10.4103/0971-9261.43025 Text en © Journal of Indian Association of Pediatric Surgeons http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Hosseini, S. M. V. Foroutan, H. R. Zeraatian, S. Sabet, B. Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease |
title | Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease |
title_full | Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease |
title_fullStr | Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease |
title_full_unstemmed | Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease |
title_short | Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease |
title_sort | botulinium toxin, as bridge to transanal pullthrough in neonate with hirschsprungs disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788448/ https://www.ncbi.nlm.nih.gov/pubmed/20011471 http://dx.doi.org/10.4103/0971-9261.43025 |
work_keys_str_mv | AT hosseinismv botuliniumtoxinasbridgetotransanalpullthroughinneonatewithhirschsprungsdisease AT foroutanhr botuliniumtoxinasbridgetotransanalpullthroughinneonatewithhirschsprungsdisease AT zeraatians botuliniumtoxinasbridgetotransanalpullthroughinneonatewithhirschsprungsdisease AT sabetb botuliniumtoxinasbridgetotransanalpullthroughinneonatewithhirschsprungsdisease |